Gene expression of lipoxygenases and leukotriene receptors along the rat nephron.
Introduction
Arachidonic acid cleaved from phospholipids by phospholipases can be oxidized along three main pathways, namely cyclooxygenase, lipoxygenase and cytochrom P-450 monoxygenase pathways, all of which appear to be relevant for kidney function. The intrarenal expression sites of cyclooxygenases have already been extensively studied and there is agreement that cyclooxygenase 1 is expressed in blood vessels including glomeruli and to a major extent in the collecting duct system. Cyclooxygenase 2 is also found in blood vessels, in medullary interstitial cells and in the macula densa cells of the distal tubule (reviewed in 16). From the cytochrom P-450 monoxygenase pathway the intrarenal localization of P-450 4A enzymes giving rise to 20-HETE has already been characterized. It turned out that P-450 4A2, A3 and A8 are rather ubiquitously expressed along the nephron, whilst P-450 4A1 was not found in any nephron segment (10) . The intrarenal distrubution of other enzymes of the cytochrom P-450 monoxygenase pathway family has not yet been determined.
Similarly, the expression of lipoxygenases in the kidney is only poorly known. There exist three classic lipoxygenases, which form 5-, 12-and 15-HETE. Lipoxygenase-5 can also generate leukotriene A4 in the presence of the 5-LOX activating protein (FLAP). Leukotriene A4 in turn is the substrate of the LT A4 hydrolase forming LT B4 binding to LT B4 receptors, and of the leukotriene C4 synthase forming the so called cysteinyl leukotrienes (LT C4, LT D4 and LT E4) binding to cysteinyl leukotriene receptors.
From this group of enzymes and receptors only the intrarenal distribution of LT A4 hydrolase has so far been determined, which was found to be expressed along the whole rat nephron (23) . In vitro data, moreover, suggest that mesangial cells and podocytes can express 12-LOX mRNA (13) .
Since HETE derived from lipoxygenase activity and leukotrienes are locally acting mediators, their intrarenal site of production probably also reflects their regions of action. Since HETE and leukotrienes exert a number of effects in the kidney such as regulation of glomerular filtration or renal vasoconstriction (2) , it appeared of interest to us to localize the key elements of the lipoxygenase / leukotriene effector group within the kidney.
Methods

Microdissection of nephron segments
Male Sprague Dawley rats, weighing 200 to 260g, having free access to tap water and standard commercial pellet chow (Altromin C1000, Lage) were used. Animals were anesthetized, decapitated and both kidneys were removed. They were immediately cooled in 4°C cold 1x phosphate buffered saline (PBS) solution, followed by decapsulation and dissection into cortex, outer and inner medulla. These zones were sliced along the tubular direction into pieces of about 2mm width. According to a modified collagenase digestion protocol from Schafer et al. (31) , the obtained pieces were incubated with 2ml collagenase solution (250 Units/ml type 2 collagenase, Worthington, 50U/mL DNAse, Sigma, 48µg/mL soybean trypsin inhibitor, Sigma, and 5mmol/L glycin, Merck, in modified Eagle´s medium (MEM), Biochrom). After 20 minutes (cortex / outer medulla) and 25 minutes (inner medulla), the supernatant was removed and added to 2mL bovine serum albumin (BSA, PAALaboratories) solution (1% BSA in MEM). The remaining kidney pieces were incubated with fresh collagenase solution and this procedure was repeated 10 to 14 times.
After sedimentation for 10 minutes on ice, the supernatant was removed again and the nephron segments were resuspended in 2ml BSA. At least 11mm of each segment and 22 glomeruli were collected on ice in tissue culture dishes. From the cortex we collected Glomeruli with (Glo+) and without arterioles (Glo-), proximal and distal convoluted tubules (PCT / DCT), cortical thick ascending limbs (cTAL), connecting and cortical collecting ducts (CCD). In the outer medulla, we differentiated between proximal straight tubules (PST), descending thin limbs (dTL), medullary thick ascending limbs (mTAL), outer medullary collecting ducts (OMCD) and outer medullary vasa recta (OMVR). In the inner medulla we collected descending / ascending thin limbs of Henle (TL) and inner medullary collecting ducts (IMCD). These segments were identified by their morphological appearance and contamination was excluded by marker primers (Table 1a, Figure1) as published by Vitzthum et al. (35) . Yeast tRNA (12µg) was added as carrier and the collected tubules were stored in 400µl GTC solution (4mol/L) at -80°C until RNA extraction.
Isolation of total RNA and RT-PCR
RNA extraction was performed according to the protocol of Chomczynski and Sacchi (4). The resulting RNA pellets were dissolved in 9µL diethylpyrocarbonate-treated water and used for reverse transcription. RNA samples from all the collected 11 mm tubules and the 22 glomeruli were diluted to a final concentration of 1mm tubules / 2µL and 2 glomeruli / 2µL. PCR products were analysed after separation by ethidium-bromide (Sigma) -stained agarose 
Real time PCR analysis
Two micrograms of whole kidney total RNA / dissected kidney zone RNA (cortex, outer medulla and inner medulla) or the resulting RNA pellets of microdissected tubules were reverse transcribed into cDNA (20µL) according to standard protocols. In brief, cDNA probes were synthesized in a 20 µL reaction with total RNA, 0,5µg oligo(dT) [12] [13] [14] [15] [16] [17] [18] annealing temperature with a 5-second hold and 72°C with a 20-second hold. Amplification was followed by a melting curve analysis to verify the accuracy of the amplicon. A negative control with tRNA or with water instead of cDNA was run with every PCR to assess specificity of the reaction. Analysis of data was performed using Light Cycler software version 3.5.3. Additionally a melting curve analysis was carried out. Standard curves for the LOX / leukotriene primers were generated by using cDNA of rat whole kidney total RNA as a template. For every zone, the ratio of the amount of the LOX / leukotriene mRNAs to that of -actin mRNA was calculated. The exact nephron specific distribution was determined by RT-PCR and PCR of the mRNA samples of the microdissected nephron segments.
Results
Zonal distribution of 5-, 12-, 15-LOX, FLAP, LT A4 hydrolase, LT C4 synthase, LT B4 receptor, CYS LT 1 and CYS LT 2 mRNA
The intrarenal expression of the enzymes and receptors of the lipoxygenase / leukotriene pathway was semiquantitatively analyzed by real time PCR, using total mRNA isolated from cortex, outer and inner medulla from two rat kidneys of two different animals.
5-LOX and FLAP expression in cortex, outer and inner medulla was at about the same level in all three zones, but the expression of FLAP mRNAs was higher than 5-LOX expression (Table 2 ). 12-LOX mRNA abundance was equally low in cortex, outer and inner medulla. 15-LOX showed a rising abundance from cortex to inner medulla. The LT A4 hydrolase mRNA expression was remarkably higher than LT C4 synthase mRNA expression, which was even decreasing from cortex to inner medulla.
In view of the leukotriene receptors, the expression of the LT B4 receptor was the strongest, followed by the CYS LT 1 receptor and the CYS LT 2 receptor expression was the lowest (Table 2 ). Only the CYS LT 2 receptor showed a slightly higher expression in the inner medulla than in outer medulla and cortex , while CYS LT 1 and LT B4 distribution showed no zonal preference.
Distribution of 5-, 12-, 15-LOX, FLAP, LT A4 hydrolase, LT C4 synthase, LT B4 receptor, Cys LT 1 and Cys LT 2 receptor mRNAs in microdissected nephron segments
The gene expression of enzymes and receptors along the rat nephron was investigated by reverse transcriptase-PCR. For each product we assayed mRNA expression in at least three pools of nephron segments, collected each from a different animal.
Localization of 15-LOX mRNA
We found a weak expression of 15-LOX mRNA in the distal nephron (Fig 2A) , beginning in the cTAL and the DCT and a strong expression along the whole collecting duct (CCD, OMCD, IMCD) (Fig. 9) . Outer medullary vasa recta did not express significant amounts of 15-LOX mRNA (Fig. 2B) .
Localization of 12-LOX mRNA
We observed 12-LOX mRNA expression in microdissected nephron segments only in the glomerulus ( Fig. 3 and Fig. 9 ). The same results were obtained with glomeruli, that had been flushed with saline prior to isolation in order to remove trapped blood cells.
Localization of 5-LOX and of FLAP mRNA
For 5-LOX, we found mRNA signals in the glomerulus and in vasa recta (Fig. 4) .
The mRNA for 5-LOX activating protein showed the same expression pattern as the mRNA for 5-LOX in microdissected nephron segments with an additional weak expression along the distal nephron from mTAL to OMCD (Fig. 5) .
Localization of LT A4 hydrolase and LT C4 synthase mRNA
The mRNA for leukotriene A4 hydrolase showed a high abundance in all nephron segments (Fig. 6 ) except the outer medullary vasa recta, where we found a weaker expression.
Leukotriene C4 synthase mRNA was detected in whole kidney, but not in any of the microdissected nephron segments (Fig. 7) .
Localization of LT B4, CYS LT 1 and CYS LT 2 mRNA
The mRNAs for cysteinyl receptor type 1 (CYS LT 1) and the leukotriene B4 receptor were highly abundant in flushed and nonflushed glomeruli ( Fig. 3 and Fig. 9 ). We observed varying signals for the leukotriene B4 receptor along the distal nephron, which we considered to be non-specific as they were not always reproducible. mRNA for the cysteinyl receptor type 2 (CYS LT 2) was not found in any microdissected nephron segment and liver, but at (as a positive control) low level in the whole kidney and brain and at higher levels in heart and lung according to published data (Fig. 8) .
Discussion
15-LOX
We found 15-LOX mRNAs along the distal nephron with increasing abundance from mTAL to CD. These findings are in accordance with increasing mRNA expression from cortex to the inner medulla in kidney zones without microdissection, probably reflecting the relatively high density of collecting ducts in the inner medulla (Fig. 10) . Small vessels, adhering to the collecting duct might have contributed to this expression pattern. We analysed four different collections of outer medullary vasa recta to assess the expression and possibly exclude contamination of the collecting duct (CCD, OMCD, IMCD). We found no 15-LOX mRNA expression in the OMVR, so contamination of adhering vessels could not be excluded, but the localization in the collecting duct was confirmed. Until now, the expression of 15-LOX was observed in blood, endothelium and lung (22) . An inhibitory role on renin release was described for 15-LOX products (1) and Munger et al (21) observed preserved renal function in experimental antiglomerular basement membrane antibody-mediated glomerulonephritis due to stimulated 15-LOX-levels. These effects could be mediated by 15-HETE binding to PPAR-gamma (9), which was found to be widely expressed from mesangial cells to medullary collecting ducts (30) . 
12-Lox
We observed 12-LOX mRNAs in microdissected nephron segments only in the glomerulus, but in no tubular compartment (Fig.9) . These results were reproducible with glomeruli that were microdissected after flushing the kidney with 0,9% NaCl solution. However, mRNA abundance was about the same in cortex, outer and inner medulla. Therefore the mRNA we detected in the kidney zones presumably originates from other cells like macrophages, endothelium or smooth muscle cells, where it already had been detected by other groups (7, 14, 15, 24) . Podocytes were shown to express 12-LOX mRNAs (13) . Matrix protein formation in mesangial cells, stimulated by high glucose, is mediated by 12-LOX (26) . Matrix protein production in other renal / interstitial cells could as well be influenced by 12-LOX.
Oyekan et al (25) have shown that ANG II induced vasoconstriction may be in part mediated by 12-LOX and increased levels of 12-HETE, which were measured in the plasma of spontaneously hypertensive rats are thought to enhance the responsiveness of vascular smooth muscle cells to angiotensin II (29) . Our observation that 12-LOX is highly abundant only in the glomerulus is in accordance with a vasoconstrictory action of 12-LOX in the glomerulus and the vasculature, thereby decreasing renal blood flow and glomerular filtration rate.
5-LOX and FLAP
We observed the expression of 5-LOX and FLAP mRNAs mainly in the glomerulus and in the OMVR (Fig. 9 ) and a weak expression of FLAP that we could not always reproduce along the distal nephron. (Table 2 ) and the weak expression of FLAP along the distal nephron (Fig. 5) .
A regulation of renal blood flow and glomerular filtration rate has been reported for 5-LOX products, i.e.5-LOX products might impair renal function (37) (6). Furthermore 5-LOX products are considered to be proinflammatory in glomerulonephritis (3). In addition, leukocytes could easily be attracted from the glomerulus and mediate glomerular but also tubulo-interstitial inflammation, as mediation of inflammation is the probably most thoroughly investigated aspect of 5-LOX products (27) .
The leukotriene receptors Cys LT 1 and LT B4 that mediate effects of 5-LOX products showed also a marked abundance in the glomerulus (Fig. 9 ). Again, in mRNA which we isolated from kidney zones, the Cys LT 1 receptor and the LT B4 receptor were almost equally abundant in all three zones. We presume that either large vessels, endothelium, local immunocompetent or interstitial cells are responsible for this observation. These results reinforce the putative role of 5-LOX products in glomeruli. In contrast to Cys LT 1 and LT B4 receptors we found no Cys LT 2 in microdissected renal tissue suggesting that Cys LT 2 is not involved in leukotriene signaling in glomeruli or tubuli. However, we observed mRNA expression of the Cys LT 2 receptor in heart and lung at higher levels, a weaker expression in brain and kidney and no expression in the liver. Takasaki et al (33) found the human Cys LT 2 receptor in embryonic kidney cells, heart and leukocytes, but only at low levels in the lung and not at all in liver tissue. Our results differ mainly concerning the higher expression in the lung. Maybe we detected Cys LT 2 mRNAs from leukocytes, because the lungs were not flushed before they were taken out, or from the pulmonary vein where the Cys LT We found no signal at all for LT C4 synthase in microdissected nephron segments, whereas we detected a low abundance in whole kidney, which was decreasing from cortex to the inner medulla (Fig. 10) . LT C4 synthase has been found in platelets, endothelium and kidney homogenates (30) . Microdissected nephron segments are free of endothelium and platelets, while the homogenated kidney zones are not. This might be one reason for our results and another one could be LT C4 synthase activity in interstitial cells. Thus glomerular and tubular structures in the kidney are clearly not involved in LT C4 synthesis.
In contrast, the LT A4 hydrolase showed a high abundance along the whole nephron, except for the OMVR, where we saw weaker signals. So we confirmed the results by Nakao et al (23) and provided the additional information that there is a relatively weak expression of LT A4 hydrolase in OMVR. These data clearly suggest a relatively higher importance of the LT A4 hydrolase pathway in the kidney compared with the LT C4 synthase pathway, especially as we found no reproducible mRNA signals of the LT C4 synthase in microdissected nephron segments.
Taking together, our data suggest that glomeruli and collecting ducts express key enzymes forming HETEs and leukotrienes and express some of their receptors. As a consequence HETEs and and leukotrienes are candidate mediators in the control of renal function. 
